Reports: ZORA Program (Slovenia): Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access]. | '''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access]. | ||
{{Vulva}} | |||
{{Vagina}} | |||
{{Cervix}} | |||
{{Uterus}} | |||
{{Ovary}} | |||
{{Fallopian tubes}} | |||
{{Endometrium}} | |||
Revision as of 18:59, 12 September 2024
Go back to Slovenia page
Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.
Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; causes of death; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.
Data level: national level.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Access to information: Click here to access.
